Filing Details
- Accession Number:
- 0001179110-11-011696
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-03 18:26:05
- Reporting Period:
- 2011-08-01
- Filing Date:
- 2011-08-03
- Accepted Time:
- 2011-08-03 18:26:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334682 | H Gregg Alton | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Corp & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-08-01 | 12,000 | $16.01 | 44,790 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-08-01 | 11,000 | $41.60 | 33,790 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-08-01 | 2,000 | $42.57 | 31,790 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-08-01 | 12,000 | $0.00 | 12,000 | $16.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,500 | 2015-01-26 | No | 4 | M | Direct |
Footnotes
- The options have a 5 year vesting schedule. 20% of the options vested on January 26, 2006, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on January 26, 2010. The options expire on January 26, 2015.
- Sale prices reported for the transactions reported here range from $41.30 to $42.21. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $42.57 to $42.58. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.
- Amount of securities beneficially owned includes 577 shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan on June 30, 2010.
Billionaire Hedge Funds
